Scientists at the University of Pittsburgh have tested a new anthrax treatment. The treatment uses growth factors to help repair damaged lung tissue. It reversed advanced damage in mice with late-stage anthrax infections. This discovery could help patients who miss the usual treatment window.
Anthrax is caused by a bacterium called Bacillus anthracis. It can enter the body through the lungs, skin, or digestion. Early symptoms often look like the flu, making diagnosis difficult. Without fast treatment, anthrax becomes deadly within just a few days.
The new study offers hope for treating advanced or missed infections. Researchers believe this method could save lives in real-world outbreaks.
